Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Nov 17, 2023 11:40am
393 Views
Post# 35741198

Information void

Information void
As usual we sit in a void with no updates on the LIFE offering.

I followed another company years ago (also TSX venture, what are the odds?) that tried to do a LIFE and didn't quite meet the minimum. They knew that they could only do one LIFE every 12 m and didn't want to spend that one raise on a sub-par raise so the announced that the LIFE was cancelled and everyone who subscribed could get the same deal as a private placement. The main difference with the PP was the 4m lock-in for selling and the warrants were not tradeable. I bring this up because those of us who are pessimistic about managment's ability to raise the full amount, could see them pulling this and buying another wimpy 4-6 m of cash runway.

So what to expect in coming days or weeks and what it means:

Scenario Medium term picture Stock price
LIFE offering filled at minimum TLT has cash, still proceed to BTD application, slow mo the GBM work increase but stalls at 0.22 as Research capital sells immediately
LIFE offering filled at maximum TLT has cash, still proceed to BTD application, proceed on the GBM work increase but stalls at 0.22 as Research capital sells immediately
LIFE offering not reaching minimum (and going to a smaller PP instead) TLT has less cash, still proceed to BTD application, stall on the GBM increase since some cash on hand, no share dump at 0.22 because locked in
No success at all Don't see that happening (?some cash will be raised) ?

No matter what I think we still plug along towards BTD and that is the key.

Love the science, have little faith in management so my bet is on LIFE minimum or switching to PP.

I dearly hope the zero success scenario (row 4) is not the case.

I only write these posts because we have no information so it fills the time :)
<< Previous
Bullboard Posts
Next >>